Skip to main content
Equibles

MDWD · MediWound Ltd. · Metrics

Track MDWD — free

Use MDWD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MDWD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.12 +0.02 (+0.17%)
Russell 2000 member Rebalance outlook locked
Market Cap
$156.21M
Shares
12.91M
Volume · Oct 21 27.25K Avg daily vol (3M) 88.37K

MDWD metrics

75 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.10
Market cap
$156.21M

Price action

20 metrics
Price change (1W)
-1.0%
Price change (30D)
-9.1%
Price change (3M)
-15.3%
Price change (6M)
-27.1%
Price change (YTD)
-34.5%
Price change (1Y)
-38.5%
Trailing year
Price change (5Y)
—
52-week high
$19.69
52-week low
$11.85
Change from 52-week high
-38.5%
Change from 52-week low
+2.1%
Annualized volatility
40.0%
Annualized volatility (3M)
37.3%
Beta
0.7
RSI (14D)
39.8
Price vs SMA 50
-8.3%
Price vs SMA 200
-21.7%
Avg volume (3M)
88,372
Relative volume
2.6
Average dollar volume
$1.18M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
12.91M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
11.7×
reciprocal yield 8.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
13.8×
reciprocal yield 7.2%
P / book
4.6
reciprocal yield 21.7%
FCF yield
-17.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-12.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
15.5%
Operating margin
-267.7%
Trailing 12 months
Net margin
-170.1%
Gross profit (TTM)
$1.83M
Operating profit (TTM)
−$31.76M
Net income (TTM)
−$20.18M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-240.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.40

Growth

11 metrics
Revenue growth YoY
-45.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$11.86M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+16.8%
Year over year · more shares
Revenue CAGR (3Y)
-13.8%
Revenue CAGR (5Y)
-4.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-56.6%
Return on assets
-28.1%
Debt / equity
0.3
Current ratio
2.3
EBITDA (TTM)
−$31.14M
Free cash flow (TTM)
−$28.53M
Quick ratio
2.1
Interest coverage
-547.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$25.62M
Latest balance sheet
Cash & equivalents
$4.34M
Total assets
$71.88M
Total debt
$9.72M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$22.14M
Capital expenditures (TTM)
$6.39M
R&D (TTM)
$19.03M
SG&A (TTM)
$15.02M
Stock compensation (TTM)
$2.80M
R&D / revenue
160.4%
Stock compensation / revenue
23.6%

Ownership (13F)

9 metrics
13F filers
78
13F filer change QoQ
+1
Institutional ownership
45.3%
Conviction holders (share of 13F filers)
1.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-7.2%
Holder tenure
8.8
Price vs estimated holder cost
-17.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.7%

Short interest

3 metrics
Short interest
14.3%
Latest settlement · 28.2 days to cover
Days to cover
28.2d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$75,447
Insider-sentiment score
44 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1593984 CUSIP M68830112 13F (30d) 15 filings 15 filers Visit website Investor relations